Winslow Evans & Crocker’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-1,072
Closed -$280K – 1143
2019
Q4
$280K Buy
+1,072
New +$282K 0.07% 244
2019
Q3
– Sell
-1,000
Closed -$276K – 1156
2019
Q2
$276K Sell
1,000
-250
-20% -$61.6K 0.08% 252
2019
Q1
$280K Hold
1,250
– – 0.08% 243
2018
Q4
$234K Sell
1,250
-1,400
-53% -$287K 0.08% 240
2018
Q3
$662K Hold
2,650
– – 0.2% 116
2018
Q2
$578K Buy
2,650
+1,650
+165% +$340K 0.18% 128
2018
Q1
$191K Hold
1,000
– – 0.06% 258
2017
Q4
$156K Sell
1,000
-800
-44% -$126K 0.05% 298
2017
Q3
$280K Sell
1,800
-2,100
-54% -$332K 0.09% 209
2017
Q2
$629K Buy
+3,900
New +$633K 0.17% 134
2016
Q4
– Sell
-2,360
Closed -$266K – 1275
2016
Q3
$266K Sell
2,360
-5,000
-68% -$527K 0.08% 257
2016
Q2
$683K Buy
7,360
+1,050
+17% +$90.2K 0.2% 106
2016
Q1
$494K Hold
6,310
– – 0.15% 148
2015
Q4
$460K Buy
6,310
+50
+0.8% +$3.57K 0.13% 166
2015
Q3
$465K Hold
6,260
– – 0.15% 147
2015
Q2
$402K Sell
6,260
-1,632
-21% -$113K 0.11% 193
2015
Q1
$610K Buy
7,892
+2,368
+43% +$184K 0.17% 132
2014
Q4
$409K Buy
5,524
+5,432
+5,904% +$381K 0.12% 181
2014
Q3
$5.42K Hold
92
– – ﹤0.01% 1063
2014
Q2
$6.14K Hold
92
– – ﹤0.01% 977
2014
Q1
$5.58K Hold
92
– – ﹤0.01% 999
2013
Q4
$5K Buy
+92
New +$4.84K ﹤0.01% 1133

Other funds holding IDXX

Winslow Evans & Crocker's IDXX Position: Q1 2020 in Review

Winslow Evans & Crocker sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 1,072 shares — an estimated $280K sold.

Winslow Evans & Crocker first reported a position in IDXX in Q4 2013 and held it in 22 quarters. The position peaked at $683K in Q2 2016. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Winslow Evans & Crocker reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 1,072 Idexx Laboratories shares in Q1 2020, an estimated $280K.
  • Winslow Evans & Crocker first reported a position in Idexx Laboratories in Q4 2013 and held it in 22 quarters.
  • Winslow Evans & Crocker's Idexx Laboratories position peaked at $683K in Q2 2016.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Winslow Evans & Crocker's 13F filing for Q1 2020, filed 20 Apr 2020.